Jul 29, 2022 | DKD
2a) @ERAkidney #ERA22 is a primary international scientific symposium for interaction and exchange among basic scientists and clinicians working in #Nephrology. Our expert author is Dr. Clara García Carro (@ClaraGCarro) from San Carlos Clinical Hospital (Madrid,...
Jul 26, 2022 | DKD
2) @ERAkidney #ERA22 is a primary international scientific symposium for interaction and exchange among basic scientists and clinicians working in #Nephrology. It was held in May. Our expert author is Dr. Sheila Bermejo (@shbermejo) from @vallhebron in Barcelona,...
Jun 7, 2022 | DKD
2) This program is intended for healthcare professionals and is supported by an educational grant from Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly Company. See archived programs, all by expert authors, still available for credit at...
May 10, 2022 | DKD
1) Welcome to a new #accredited #tweetorial on the MoA & Renal Impact of Therapies Commonly Used in Pts with or At Risk for #DKD Progression: Improved Glycemic Control & #RAASi. Our expert author is Hans-Joachim Anders, MD, @hjanders_hans from @LMU_Uniklinikum...
Apr 27, 2022 | DKD
2) This #accredited #tweetorial series on the foundations of #kidneydisease #DKD through the lens of #T2D is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance and is intended for healthcare providers.— @CKD_ce (@ckd_ce)...
Apr 7, 2022 | DKD
2) This #accredited #tweetorial series on #kidneydisease #DKD through the lens of #T2D is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance and is intended for healthcare providers. Faculty disclosures are at...